View |
|
DRP-3715-04
|
Ceftriaxone (As Sodium)
|
Meditrix
|
1 g
|
Powder For Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Zazen Pharma Pvt. Ltd.
|
India
|
Automatic Renewal
|
29 May 2023
|
28 September 2028
|
View |
|
DR-XY33381
|
Pioglitazone (As Hydrochloride)
|
Zolid
|
30mg
|
Tablet
|
Oral Hypoglycemic
|
Getz Pharma (Pvt.) Ltd.
|
Pakistan
|
Initial (Variation)
|
08 February 2023
|
29 December 2027
|
View |
|
DRP-3715-06
|
Ceftriaxone (As Sodium)
|
Medceft
|
1 g
|
Powder For Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Zazen Pharma Pvt. Ltd.
|
India
|
Automatic Renewal
|
07 June 2023
|
28 September 2028
|
View |
|
DRP-10434
|
ASCORBIC ACID
|
CITRUCIN
|
500mg
|
Capsule
|
VITAMIN
|
Morishita-Seggs Pharmaceuticals, Inc.
|
Philippines
|
Renewal
|
09 November 2024
|
25 November 2029
|
View |
|
DRP-10433
|
ASCORBIC ACID
|
ASCORB-C
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)
|
Capsule
|
VITAMIN
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Renewal
|
07 November 2023
|
04 February 2029
|
View |
|
DR-XY47419
|
Multivitamin + Iron
|
Ferlin
|
Each mL contains: Thiamine Hydrochloride (Vitamin B1-10mg ) Pyridoxine Hydrochloride (Vitamin B6)-5mg Cyanocobalamin (Vitamin B12)-10mcg Iron (as Ferrous Sulfate)-15mg
|
Syrup (Oral Drops)
(Cherry-Orange Flavor)
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
24 September 2021
|
24 September 2026
|
View |
|
HMRP-27
|
Blumea Balsamifera L. (Sambong Leaf)
|
Remoston
|
500mg
|
Tablet
|
Herbal Medicine (Anti-urolithiasis/Diuretic)
|
Pascual Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
22 July 2023
|
17 September 2028
|
View |
|
DRP-8455
|
Telmisartan + Hydrochlorothiazide
|
Unbranded
|
80mg/25mg
|
Tablet
|
Angiotensin II Receptor Blocker + Diuretic
|
Evertogen Life Sciences Limited
|
India
|
Renewal
|
09 October 2019
|
14 June 2029
|
View |
|
DRP-7271-02
|
Levothyroxine (as sodium)
|
Levothyrogen
|
100 mcg
|
Tablet
|
Thyroid Hormone Replacement
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
Renewal
|
10 March 2024
|
20 May 2029
|
View |
|
DR-XY47267
|
Amphotericin B
|
Amphonex
|
50mg
|
Lyophilized Powder for Intravenous Infusion
|
-
|
Bharat Serums and Vaccines Limited
|
India
|
-
|
04 November 2021
|
11 May 2026
|
View |
|
DRP-8730
|
Quetiapine (as Fumarate)
|
Quetiapro
|
200mg
|
Film-Coated Tablet
|
Antipsychotic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
10 May 2024
|
23 July 2029
|
View |
|
DRP-8731
|
Ceftriaxone (As Sodium)
|
Ceftrirex
|
1g
|
Powder For Solution For Injection (IM/IV)
|
-
|
Jiangxi Xier Kangtai Pharmaceutical Co., Ltd.
|
China
|
-
|
19 February 2020
|
28 January 2025
|
View |
|
DRP-8733
|
Dutasteride
|
Dugen
|
500 mcg
|
Film-Coated Tablet
|
5-Alpha Reductase Inhibitor
|
Sydler Remedies Pvt. Ltd.
|
India
|
Renewal
|
15 August 2024
|
01 December 2029
|
View |
|
DRP-8735
|
Bortezomib
|
Bortesum
|
3.5 mg/VIAL
|
Lyophilized Powder For Injection (Iv/Sc)
|
Antineoplastic Agent
|
Sun Pharmaceutical Industries Ltd., India
|
India
|
Renewal
|
27 April 2022
|
03 October 2027
|
View |
|
DRP-8737
|
Capecitabine
|
Caxeta 500
|
500 mg
|
Film-Coated Tablet
|
Antineoplastic (Cell Cycle-Specific Agent)
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Automatic Renewal
|
20 July 2023
|
08 November 2028
|
View |
|
DRP-8738
|
Temozolomide
|
Gliotem 250
|
250 mg
|
Hard Gelatin Capsule
|
Antineoplastic Agent
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial (Variation)
|
15 April 2024
|
15 April 2029
|
View |
|
DRP-8739
|
Temozolomide
|
Gliotem 100
|
100 mg
|
Hard Gelatin Capsule
|
Antineoplastic Agent
|
Sun Pharmaceutical Industries Limited
|
India
|
Initial (Variation)
|
15 April 2024
|
15 April 2029
|
View |
|
DRP-8740
|
Doxorubicin Hydrochloride
|
Chemodox
|
2 mg/mL
|
Pegylated Liposomal Concentrate Solution for IV Infusion
|
Antineoplastic (Anthracycline)
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Renewal
|
23 August 2022
|
05 February 2028
|
View |
|
DRP-8742
|
Esomeprazole (As Sodium)
|
Sompraz IV
|
40 mg
|
Lyophilized Powder For Injection (Iv)
|
Proton Pump Inhibitor
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Automatic Renewal
|
03 October 2022
|
08 April 2028
|
View |
|
DRP-8743
|
Zoledronic Acid
|
Zobone
|
4 mg/5 mL
|
Concentrate Solution For Infusion (I.V.)
|
Bisphosphonate
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Automatic Renewal
|
20 January 2023
|
13 August 2028
|